The International Registry For Glucocorticoid-Remediable Aldosteronism

The following is a partial list of published literature about GRA. Reprints are available for some of the journal articles listed. Please contact the GRA Registry at 1-800-722-5520, ext. 25011, to inquire about the availability of reprints.

1. Sutherland DJ, Ruse JL, Laidlaw JC. 1966. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J;95:1109-1119
2. Ulick S, Chan CK, Gill JR, et al. 1990. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab;71:1511-1157. Abstract
3. Lifton RP, Dluhy RG, Powers M, et al.1992.A Chimaeric 11 beta-hydoxylase/aldosterone synthase gene causes glucocrtioid-remediable aldosteronism and human hypertension. Nature;355:262-265. Abstract
4. Lifton RP, Dluhy RG, Powers M, et al. 1992 Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genetics;2:66-74. Abstract
5. Rich GM, Ulick S, Cook S, Wang JZ, Lifton RP, Dluhy RG. 1992. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med;116:813-820. Abstract
6. Dluhy RG, and Lifton RP. 1994. Glucocorticoid-remediable Aldosteronism. Endocrinol Metab Clin North Am;23(2):285-297. Abstract
7. Dluhy RG, and Lifton RP. Glucocorticoid-Remediable Aldosteronism (GRA). Steroids. 1995 Jan;60(1):48-51. Abstract
8. Litchfield WR, Dluhy RG, Lifton RP, Rich GM. Glucocorticoid-Remediable Aldosteronism. Compr Ther. 1995 Oct;21(10):553-8. Abstract
9. Williams GH, Dluhy RG. Glucocorticoid-Remediable Aldosteronism. J Endocrinol Invest. 1995 Jul-Aug;18(7):512-7. Abstract
10. Carroll J, Dluhy R, Fallo F, Pistorello M, Bradwin G, Gomez-Sanchez CE, Mortensen R. Aldosterone-Producing Adenomas Do Not Contain Glucocorticoid-Remediable Aldosteronism Chimeric Gene Duplications. J Clin Endocrinol Metab. 1996 Dec;81(12):4310-2. Abstract
11. Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, and Dluhy RG 1998. Intracranial aneurysm and hemorrhagic stroke in Glucocorticoid- remediable aldosteronism. Hypertension;31[part 2]:445-450. Abstract
12. Litchfield WR, Coolidge C, Silva P, Lifton RP, Fallo F, Williams, GH and Dluhy RG 1997. Impaired potassium-stimulated aldosterone production: a possible explanation for normkalemic Glucocorticoid-remediable aldsoteronism. J Clin Endo Metab;82(5):1507-1510. Abstract
13. Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG 1997. Evaluation of the dexamethasone suppression test for the diagnosis of Glucocorticoid-remediable aldosteronism. J Clin Endo Metab;82(11):3570- 3573. Abstract
14. Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, and Dluhy RG 1998. Intracranial aneurysm and hemorrhagic stroke in Glucocorticoid- remediable aldosteronism. Hypertension;31[part 2]:445-450. Abstract
15. Wyckoff JA, Seely EW, Hurwitz S, Anderson BF, Lifton RP, Dluhy RG. Glucocorticoid-Remediable Aldosteronism and Pregnancy. Hypertension 2000 Feb;35(2):668-72. Abstract
16. Dluhy RG, Anderson B, Harlin B, Ingelfinger J, Lifton R.  Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. Journal of Pediatrics 2001 May;138(5):715-20. Abstract